Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Daily News

Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis

Caitlin E. Cox

October 27, 2021

News Daily News

‘Gaming’ the AUC for Revascularization? Study Suggests Not

Michael O'Riordan

March 25, 2021

News Daily News

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

Todd Neale

December 23, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

News Daily News

Meta-analysis Supports Benefits of Short-term DAPT Among Elderly Patients

Yael L. Maxwell

February 20, 2018

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Daily News

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Yael L. Maxwell

October 23, 2017

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

News Daily News

登记表数据显示原发性 PCI 患者比伐卢定与肝素使用率波动

Yael L. Maxwell

November 11, 2016

News Daily News

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

November 11, 2016

News Daily News

Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias

Yael L. Maxwell

November 11, 2016

News Daily News

Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge

Todd Neale

October 18, 2016

News Conference News AHA 2015

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Yael L. Maxwell

November 09, 2015

Advertisement

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Many STEMI Patients Not Treated Within National Time Goals

New Biomarker-Based Risk Score Performs Well in ACS

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Nonfatal MI Not a Death Surrogate in Cardiology: Meta-analysis

‘Gaming’ the AUC for Revascularization? Study Suggests Not

NOBLE at 5 Years: New Data Favor CABG for Left Main Disease

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Meta-analysis Supports Benefits of Short-term DAPT Among Elderly Patients

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

登记表数据显示原发性 PCI 患者比伐卢定与肝素使用率波动

Registry Data Show Rise and Fall of Bivalirudin vs Heparin for Primary PCI

Datos de Registro Revelan el Ascenso y Caída de la Bivalirudina frente a la Heparina en la Realización de PCI Primarias

Oral Anticoagulation Use Common in PCI Patients, With Triple Therapy the Norm at Discharge

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content